| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order | 
|---|---|---|---|---|---|---|
| GC38358-5g |  | 63-37-6 | 5’-Cytidylic acid 
 | 0 | C9H14N3O8P | |
| GC38358-500mg |  | 63-37-6 | 5’-Cytidylic acid 
 | 0 | C9H14N3O8P | |
| GC38357-1g |  | 21645-51-2 | Aluminum Hydroxide 
 | 0 | AlH3O3 | |
| GC38357-500mg |  | 21645-51-2 | Aluminum Hydroxide 
 | 0 | AlH3O3 | |
| GC38356-5g |  | 3251-69-2 | Imidazoleacetic acid hydrochloride 
 | 0 | C5H7ClN2O2 | |
| GC38356-500mg |  | 3251-69-2 | Imidazoleacetic acid hydrochloride 
 | 0 | C5H7ClN2O2 | |
| GC38355-100mg |  | 796073-70-6 | DM3-SMe 
 | 0 | C38H54ClN3O10S2 | |
| GC38354-100mg |  | 236102-87-7 | Seco-Duocarmycin TM 
 | 0 | C25H24N2O6 | |
| GC38354-25mg |  | 236102-87-7 | Seco-Duocarmycin TM 
 | 0 | C25H24N2O6 | |
| GC38353-1mg |  | 1395946-75-4 | APX-115 
 | 0 | C17H18ClN3O | |
| GC38352-5mg |  | — | Orexin A (human, rat, mouse) (TFA) 
 | 0 | C154H244N47F3O46S4 | |
| GC38352-1mg |  | — | Orexin A (human, rat, mouse) (TFA) 
 | 0 | C154H244N47F3O46S4 | |
| GC38351-5mg |  | 356568-70-2 | Barbadin 
 | 0 | C19H15N3OS | |
| GC38351-2mg |  | 356568-70-2 | Barbadin 
 | 0 | C19H15N3OS | |
| GC38351-1mg |  | 356568-70-2 | Barbadin 
 | 0 | C19H15N3OS | |
| GC38351-10mM (in 1mL DMSO) |  | 356568-70-2 | Barbadin 
 | 0 | C19H15N3OS | |
| GC38350-100mg |  | 2071195-74-7 | Epertinib hydrochloride 
 | 0 | C30H28Cl2FN5O3 | |
| GC38350-50mg |  | 2071195-74-7 | Epertinib hydrochloride 
 | 0 | C30H28Cl2FN5O3 | |
| GC38350-10mg |  | 2071195-74-7 | Epertinib hydrochloride 
 | 0 | C30H28Cl2FN5O3 | |
| GC38350-5mg |  | 2071195-74-7 | Epertinib hydrochloride 
 | 0 | C30H28Cl2FN5O3 | |